In luminal breast cancer cells, HER-2 overexpression can block TGF-β mediated cell cycle arrest by a previously unreported mechanism that does not involve the abrogation of Smad nuclear accumulation, DNA binding or changes in c-myc repression. The gene discussed is TGFB1; the disease is breast cancer.